MPEP § 2419 — Publishing of Patent Grants and Patent Application Publications with a “Sequence Listing XML”
Ninth Edition, Revision 01.2024 · last revised R-01.2024
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
At the USPTO, the Sequence Listing Information Control (SLIC) system is responsible for processing of a “Sequence Listing XML” and exporting the sequence data for publication and grant. Because a “Sequence Listing XML” exists only in .xml file format, the USPTO uses a style sheet to transform a “Sequence Listing XML” file of less than 1 GB in size into an ASCII text file which will be used to present the sequence information in a format that is more easily read.
Contents
- 2419.01 Patent Grants and Patent Application Publications Containing a Non-Lengthy “Sequence Listing XML”
- 2419.02 Patent Grants and Patent Application Publications Containing a Lengthy “Sequence Listing XML”
- 2419.03 Patent Grants and Patent Application Publications Containing a “Sequence Listing XML” of 1GB or Larger
Cited authority
Cited by
- 1121 Content of a Patent Application Publication
- 1823.02 Filing Nucleotide and/or Amino Acid Sequence Listings in International Applications
- 1848 Sequence Listings
- 2419.03 Patent Grants and Patent Application Publications Containing a “Sequence Listing XML” of 1GB or Larger
- 2420 The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures under World Intellectual Property Office Standard ST.25 (WIPO ST.25) - the Sequence Rules
- 2421.01 Definition of “Sequence Listing” and Computer Readable Form (CRF)
- 2421.02 Summary of the Requirements of the Sequence Rules
- 2421.03 Notification of a Failure to Comply
- 2422 Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications Subject to WIPO ST.25
- 2422.01 Nucleotide and/or Amino Acids Disclosures Requiring a “Sequence Listing”
- 2422.02 The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures
- 2422.03 Sequence Listing Submission
- 2422.03(a) “Sequence Listing” Submitted as ASCII Plain Text Files
- 2422.04 The Requirement for a Computer Readable Copy of the “Sequence Listing”
- 2422.06 Requirement for Statement Regarding Information Contained in the “Sequence Listing” and Separate Computer Readable Form
- 2422.07 Requirements for Compliance and Consequences of Non-Compliance
- 2422.08 Presumptions Regarding Compliance
- 2423 Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data for WIPO ST.25
- 2423.01 Format and Symbols To Be Used in a “Sequence Listing”
- 2423.02 Depiction of Coding Regions
- 2423.03 Presentation and Numbering of Sequences
- 2424 Requirements for Content of a “Sequence Listing” Part of the Specification under WIPO ST.25.
- 2424.01 Informational Requirements for the “Sequence Listing”
- 2424.02 “Sequence Listing” Numeric Identifiers
- 2424.03 Additional Miscellaneous Requirements
- 2425 Form and Format for a Nucleotide and/or Amino Acid Sequence Submission as an ASCII Plain Text File under WIPO ST.25
- 2426 Amendments to Add or Replace a “Sequence Listing” and CRF Copy Thereof Subject to WIPO ST. 25
- 2427 Form Paragraphs for Applications Subject to WIPO ST.25
- 2428 Sample Statements under WIPO ST.25
- 2429 Helpful Hints for Sequence Rules Compliance under WIPO ST.25
- 2430 PatentIn Information
- 2431 Sample “Sequence Listing” under WIPO ST.25
- 608.05(c) Submissions of Biological Sequence Listings